BioMed Research International

BioMed Research International / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 9042956 | https://doi.org/10.1155/2019/9042956

Valerio Mezzasalma, Enrico Manfrini, Emanuele Ferri, Anna Sandionigi, Barbara La Ferla, Irene Schiano, Angela Michelotti, Vincenzo Nobile, Massimo Labra, Patrizia Di Gennaro, "Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”", BioMed Research International, vol. 2019, Article ID 9042956, 1 page, 2019. https://doi.org/10.1155/2019/9042956

Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”

Received26 Feb 2019
Accepted03 Mar 2019
Published09 Apr 2019

In the article titled “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation” [1], the number of probiotics in the formulation mixtures in subsection “2.1. Study Design” in Materials and Methods was written incorrectly as follows:

“The composition of the probiotic mix F_1 was as follows: 5 × 109 CFU L. acidophilus (30 mg as lyophilized), 5 × 109 CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 5 × 109 CFU L. plantarum (12 mg as lyophilized), 5 × 109 CFU L. rhamnosus (20 mg as lyophilized), 5 × 109 CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, 5 mg talc.”

It should be corrected to the following: “The composition of the probiotic mix F_1 was as follows: 2 × 109 CFU L. acidophilus (30 mg as lyophilized), 2 × 109 CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 2 × 109 CFU L. plantarum (12 mg as lyophilized), 2 × 109 CFU L. rhamnosus (20 mg as lyophilized), 2 × 109 CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, and 5 mg talc.”

References

  1. V. Mezzasalma, E. Manfrini, E. Ferri et al., “A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation,” BioMed Research International, vol. 2016, Article ID 4740907, 10 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2019 Valerio Mezzasalma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views614
Downloads420
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.